A Detailed Analysis of the Antibody Discovery Market Based on Rising Demand for Personalized Medicine, Advancements in Biotechnology, and an Increased Focus on Targeted Therapies for Various Diseases, Particularly in Oncology
Industry: Healthcare
Published Date: January-2024
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 191
Report ID: PMRREP33749
1. Executive Summary
1.1. Global Antibody Discovery Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Method Lifecycle Analysis
2.4. Antibody Discovery Market: Value Chain
2.4.1. List of Raw Material Supplier
2.4.2. List of Manufacturers
2.4.3. List of Distributors
2.4.4. List of Applications
2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
2.7.1. Global Sectorial Outlook
2.7.2. Global GDP Growth Outlook
2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape
3. Global Antibody Discovery Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
3.1. Key Highlights
3.1.1. Market Volume (Units) Projections
3.1.2. Market Size and Y-o-Y Growth
3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
3.2.1. Historical Market Size Analysis, 2013-2016
3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global Antibody Discovery Market Outlook: Method
3.3.1. Introduction / Key Findings
3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Method, 2018 - 2022
3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Method, 2023 - 2030
3.3.3.1. Phage Display
3.3.3.2. Hybridoma
3.3.3.3. Others
3.4. Market Attractiveness Analysis: Method
3.5. Global Antibody Discovery Market Outlook: Antibody Type
3.5.1. Introduction / Key Findings
3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Antibody Type, 2018 - 2022
3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Antibody Type, 2023 - 2030
3.5.3.1. Humanized Antibody
3.5.3.2. Human Antibody
3.5.3.3. Chimeric Antibody
3.5.3.4. Murine Antibody
3.6. Market Attractiveness Analysis: Antibody Type
3.7. Global Antibody Discovery Market Outlook: End User
3.7.1. Introduction / Key Findings
3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 - 2022
3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
3.7.3.1. Pharmaceutical and Biotechnology industry
3.7.3.2. Research laboratory
3.7.3.3. Academic laboratory
3.8. Market Attractiveness Analysis: End User
4. Global Antibody Discovery Market Outlook: Region
4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
4.3.1. North America
4.3.2. Europe
4.3.3. East Asia
4.3.4. South Asia & Pacific
4.3.5. Latin America
4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region
5. North America Antibody Discovery Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
5.3.1. By Country
5.3.2. By Method
5.3.3. By Antibody Type
5.3.4. By End User
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
5.4.1. U.S.
5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Method, 2023 - 2030
5.5.1. Phage Display
5.5.2. Hybridoma
5.5.3. Others
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Antibody Type, 2023 - 2030
5.6.1. Humanized Antibody
5.6.2. Human Antibody
5.6.3. Chimeric Antibody
5.6.4. Murine Antibody
5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
5.7.1. Pharmaceutical and Biotechnology industry
5.7.2. Research laboratory
5.7.3. Academic laboratory
5.8. Market Attractiveness Analysis
6. Europe Antibody Discovery Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
6.3.1. By Country
6.3.2. By Method
6.3.3. By Antibody Type
6.3.4. By End User
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
6.4.1. Germany
6.4.2. France
6.4.3. U.K.
6.4.4. Italy
6.4.5. Spain
6.4.6. Russia
6.4.7. Turkey
6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Method, 2023 - 2030
6.5.1. Phage Display
6.5.2. Hybridoma
6.5.3. Others
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Antibody Type, 2023 - 2030
6.6.1. Humanized Antibody
6.6.2. Human Antibody
6.6.3. Chimeric Antibody
6.6.4. Murine Antibody
6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
6.7.1. Pharmaceutical and Biotechnology industry
6.7.2. Research laboratory
6.7.3. Academic laboratory
6.8. Market Attractiveness Analysis
7. East Asia Antibody Discovery Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
7.3.1. By Country
7.3.2. By Method
7.3.3. By Antibody Type
7.3.4. By End User
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
7.4.1. China
7.4.2. Japan
7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Method, 2023 - 2030
7.5.1. Phage Display
7.5.2. Hybridoma
7.5.3. Others
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Antibody Type, 2023 - 2030
7.6.1. Humanized Antibody
7.6.2. Human Antibody
7.6.3. Chimeric Antibody
7.6.4. Murine Antibody
7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
7.7.1. Pharmaceutical and Biotechnology industry
7.7.2. Research laboratory
7.7.3. Academic laboratory
7.8. Market Attractiveness Analysis
8. South Asia & Oceania Antibody Discovery Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
8.3.1. By Country
8.3.2. By Method
8.3.3. By Antibody Type
8.3.4. By End User
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
8.4.1. India
8.4.2. Southeast Asia
8.4.3. ANZ
8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Method, 2023 - 2030
8.5.1. Phage Display
8.5.2. Hybridoma
8.5.3. Others
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Antibody Type, 2023 - 2030
8.6.1. Humanized Antibody
8.6.2. Human Antibody
8.6.3. Chimeric Antibody
8.6.4. Murine Antibody
8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
8.7.1. Pharmaceutical and Biotechnology industry
8.7.2. Research laboratory
8.7.3. Academic laboratory
8.8. Market Attractiveness Analysis
9. Latin America Antibody Discovery Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
9.3.1. By Country
9.3.2. By Method
9.3.3. By Antibody Type
9.3.4. By End User
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Method, 2023 - 2030
9.5.1. Phage Display
9.5.2. Hybridoma
9.5.3. Others
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Antibody Type, 2023 - 2030
9.6.1. Humanized Antibody
9.6.2. Human Antibody
9.6.3. Chimeric Antibody
9.6.4. Murine Antibody
9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
9.7.1. Pharmaceutical and Biotechnology industry
9.7.2. Research laboratory
9.7.3. Academic laboratory
9.8. Market Attractiveness Analysis
10. Middle East & Africa Antibody Discovery Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
10.3.1. By Country
10.3.2. By Method
10.3.3. By Antibody Type
10.3.4. By End User
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
10.4.1. GCC
10.4.2. Egypt
10.4.3. South Africa
10.4.4. Northern Africa
10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Method, 2023 - 2030
10.5.1. Phage Display
10.5.2. Hybridoma
10.5.3. Others
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Antibody Type, 2023 - 2030
10.6.1. Humanized Antibody
10.6.2. Human Antibody
10.6.3. Chimeric Antibody
10.6.4. Murine Antibody
10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
10.7.1. Pharmaceutical and Biotechnology industry
10.7.2. Research laboratory
10.7.3. Academic laboratory
10.8. Market Attractiveness Analysis
11. Competition Landscape
11.1. Market Share Analysis, 2022
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition Hybridoma
11.2.3. Apparent Product Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
11.3.1. Alcami Corporation, Inc.
11.3.1.1. Overview
11.3.1.2. Segments and Product
11.3.1.3. Key Financials
11.3.1.4. Market Developments
11.3.1.5. Market Strategy
11.3.2. BASF SE
11.3.2.1. Overview
11.3.2.2. Segments and Product
11.3.2.3. Key Financials
11.3.2.4. Market Developments
11.3.2.5. Market Strategy
11.3.3. Bioduro-Sundia
11.3.3.1. Overview
11.3.3.2. Segments and Product
11.3.3.3. Key Financials
11.3.3.4. Market Developments
11.3.3.5. Market Strategy
11.3.4. Bruker
11.3.4.1. Overview
11.3.4.2. Segments and Product
11.3.4.3. Key Financials
11.3.4.4. Market Developments
11.3.4.5. Market Strategy
11.3.5. Cambrex Corporation
11.3.5.1. Overview
11.3.5.2. Segments and Product
11.3.5.3. Key Financials
11.3.5.4. Market Developments
11.3.5.5. Market Strategy
11.3.6. Croda International Plc
11.3.6.1. Overview
11.3.6.2. Segments and Product
11.3.6.3. Key Financials
11.3.6.4. Market Developments
11.3.6.5. Market Strategy
11.3.7. Aragen Life Sciences Pvt. Ltd
11.3.7.1. Overview
11.3.7.2. Segments and Product
11.3.7.3. Key Financials
11.3.7.4. Market Developments
11.3.7.5. Market Strategy
11.3.8. Eurofins DiscoverX Corporation
11.3.8.1. Overview
11.3.8.2. Segments and Product
11.3.8.3. Key Financials
11.3.8.4. Market Developments
11.3.8.5. Market Strategy
11.3.9. NanoCellect Biomedical
11.3.9.1. Overview
11.3.9.2. Segments and Product
11.3.9.3. Key Financials
11.3.9.4. Market Developments
11.3.9.5. Market Strategy
11.3.10. Sartorius AG
11.3.10.1. Overview
11.3.10.2. Segments and Product
11.3.10.3. Key Financials
11.3.10.4. Market Developments
11.3.10.5. Market Strategy
12. Appendix
12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations
Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
